This indicator may be signaling that MRUS's price has further to drop, since it moved below its price 14 days ago. Traders may consider selling the stock, shorting the stock, or exploring put options...
Pancreatic Cancer Research Gains Momentum Amidst Soaring Young-Onset Cases Pancreatic Cancer Research Gains Momentum Amidst Soaring Young-Onset Cases PR Newswire VANCOUVER, British Columbia, Sept...
Needham Company LLC reissued their buy rating on shares of Merus (NASDAQ:MRUS Free Report) in a report published on Thursday, Benzinga reports. The firm currently has a $45.00 price...